Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure
NCT00633477
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class
Stopped
Business Decision; No Safety Or Efficacy Concerns.
Conditions
Sepsis
Interventions
DRUG:
Resatorvid
DRUG:
Placebo
Sponsor
Takeda